Why Amazon stock stumbled today

Investors sell out of the company, albeit modestly, after a rival's bid is selected for a choice asset.

| More on:
A businessman slips and spills his coffee.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Monster retailer Amazon (NASDAQ: AMZN) doesn't often lose, so shareholders get discouraged when the company doesn't come in first in a contest. That was the situation on Tuesday, when a rival's bid was selected for a big healthcare asset that was in play. As a result, Amazon's share price closed the day over 1% lower, a steeper fall than that of the S&P 500 index.

So what

Amazon was vying for healthcare services company Signify Health, but the nod ended up going to CVS Health, whose bid was worth roughly $8 billion. Other companies participating in the effort to acquire Signify were UnitedHealth Group and Option Care Health.

Among that crowd, Amazon was a bit of an outlier. UnitedHealth and Option Care are pure-play healthcare companies. Amazon, which has always aimed to be a retailer of any product or service imaginable, is still considered by many to be more of a giant online shopping outlet than a provider of healthcare services.

In Signify's press release announcing its selection of CVS, CEO Kyle Armbrester said that "we determined that CVS Health is the ideal partner, given its focus on expanding access to health services and helping consumers navigate to the best sites of care."

While Amazon has indisputably made strides in its medical business efforts -- witness its $3.9 billion deal for primary care provider 1Life Healthcare earlier this year -- it still isn't readily identified with that sector. It wouldn't be surprising if this made the company a dark horse candidate, at best, in the Signify bidding.

Now what

Amazon isn't known for setbacks and management probably isn't too fond of them, so we can expect the company to make fresh bids for other healthcare businesses that come into play. But other entities with deep pockets will also be looking to buy, so Signify might not be the last of its defeats in the sector.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on International Stock News

Woman and man calculating a dividend yield.
International Stock News

Alphabet stock jumped 13.9% in November. What's next?

Alphabet proved it doesn't need Nvidia to compete at the frontier.

Read more »

A man has a surprised and relieved expression on his face.
International Stock News

If you'd invested $3,500 in Tesla 12 years ago, here's how much you'd have today

Tesla is now one of the largest publicly traded companies on the stock market.

Read more »

Woman and man calculating a dividend yield.
International Stock News

Meta Platforms stock jumps on Metaverse spending cuts. Here's why the growth stock is a screaming buy before 2026

Wall Street is sending a clear signal to Meta Platforms that it wants the company to reduce spending on Reality…

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
International Stock News

3 reasons to buy Nvidia stock like there's no tomorrow

The GPU leader's share price has retreated from its all-time high, but this is an excellent time to buy.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
International Stock News

If you'd invested $1,000 in Nvidia 5 years ago, here's how much you'd have today

Nvidia has gone from a relatively under-the-radar chipmaker to the world's most valuable public company.

Read more »

Piggy bank on US flag with stock market data.
Share Market News

US stocks outperform ASX 200 for third consecutive year: Is it time to bail?

In the year to date, the S&P 500 Index is up 16.4% while the ASX 200 is up 5%.

Read more »

Legendary share market investing expert and owner of Berkshire Hathaway, Warren Buffett.
International Stock News

1 reason now is a great time to buy Berkshire Hathaway stock

Technically speaking, there's one reason to buy Berkshire Hathaway, but it is made up of billions of smaller reasons.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
International Stock News

Better artificial intelligence stock: Palantir Technologies vs. Nvidia

Palantir and Nvidia have both crushed the market since ChatGPT launched, but which AI titan deserves your money today? The…

Read more »